In this particular context, we propose an innovative methodology to specifically target NTERA-2 cancer stem-like cells by utilizing a hybrid nanocarrier system consisting of niosomes and zinc nanoparticles that encapsulate decoy oligodeoxynucleotides (ODNs) that target Sox2 and Oct4 transcription factors [20]. Here, SOX2 is linked to cancer.